Top Markets
#1 Black Phoenix Black Phoenix +831.35%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +29.79%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.50%
#4 Beam Beam +26.38%
#5 SAFEcoin SAFEcoin +20.76%
#6 Magma Finance Magma Finance +20.25%
#7 pipedog pipedog +19.56%
#8 PondCoin PondCoin +18.82%
#9 THORChain THORChain +16.58%
#10 Bless Bless +16.25%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
주식 순위 #6153
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
주가
$156.13
시가총액
$2.24B
변동 (1일)
1.17%
변동 (1년)
176.58%
국가
US
거래 Palvella Therapeutics, Inc. (PVLA)

카테고리

Healthcare
Palvella Therapeutics, Inc. (PVLA)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Palvella Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Palvella Therapeutics, Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH